Chemtura

Chemtura
source
Name	Chemtura Corporation
Type	Public (formerly)
Industry	Chemicals
Fate	Acquired by LANXESS (2017)
Founded	2005 (merger of Great Lakes Chemical and Crompton)
Headquarters	Middlebury, Connecticut, United States
Key people	Peter R. Dolan (former CEO), Donald S. Stebbins (former CEO)
Products	Flame retardants, engineered intermediates, agricultural chemicals, specialty chemicals
Revenue	US$ ~2.3 billion (2012)
Employees	~4,300 (2013)
Website	(defunct)

Chemtura

Chemtura was a global specialty chemicals company formed in 2005 by the merger of Great Lakes Chemical Corporation and Crompton Corporation. It produced flame retardants, lubricant additives, industrial chemicals, and agricultural intermediates, serving markets in automotive industry, aerospace industry, construction industry, and electronics industry. Headquartered in Middlebury, Connecticut, the firm operated internationally until its acquisition by LANXESS AG in 2017.

History

Chemtura originated from the consolidation of legacy firms with roots in 19th and 20th century chemical manufacture. Great Lakes Chemical Corporation traced origins to companies active in the Lake Erie region and growth linked to postwar petrochemical expansion, while Crompton descended from specialty chemical and pigment enterprises that evolved through mergers and divestitures. The 2005 merger created a diversified specialty chemicals portfolio, which the company adjusted amid commodity price volatility, changing regulation, and shifts in globalization and supply chains. Chemtura pursued acquisitions and spin-offs, reorganized product lines, and navigated the 2008–2009 financial crisis alongside competitors such as AkzoNobel, Dow Chemical Company, BASF SE, and Huntsman Corporation. Strategic realignments culminated in interest from European chemical groups, and in 2017 Chemtura was acquired by LANXESS AG, integrating many operations into LANXESS's Additives and specialty segments.

Products and Technologies

Chemtura's portfolio included flame retardants, lubricant additives, crop protection intermediates, industrial intermediates, and polymer additives. Its flame retardant offerings targeted applications in electronics industry devices, telecommunications infrastructure, textile industry fabrics, and building construction materials. Lubricant and fuel additives served customers in the automotive industry and marine industry, while organometallic intermediates and brominated compounds supported production in pharmaceutical industry supply chains and pesticide manufacture. Technology development incorporated formulation science, organobromine chemistry, halogen-free alternatives, and functional surface treatments to meet standards set by bodies like Underwriters Laboratories and international product-safety regulations. Chemtura also marketed niche specialty chemicals for industrial process control and corrosion inhibition used by firms such as General Electric, Ford Motor Company, and Siemens.

Operations and Facilities

Chemtura operated manufacturing sites, research centers, and commercial offices across North America, Europe, and Asia. Major facilities were located in the United States, the United Kingdom, the Netherlands, and China, with supply chains linked to ports and industrial clusters such as Houston, Rotterdam, Shanghai, and Mumbai. The company's research and development efforts collaborated with academic institutions and testing laboratories including University of Connecticut, Imperial College London, and independent certification organizations. Logistics and production scheduling had to coordinate with international trade frameworks and customs regimes involving authorities like the United States Environmental Protection Agency and European regulators. Chemtura's workforce included chemists, process engineers, regulatory affairs specialists, and commercial teams servicing original equipment manufacturers such as Boeing, Fiat Chrysler Automobiles, and Samsung.

Environmental and Health Issues

Chemtura's use and manufacture of brominated flame retardants, organobromine intermediates, and other halogenated compounds attracted scrutiny from environmental groups, public health researchers, and regulatory agencies. Debates centered on persistence, bioaccumulation, potential endocrine-disrupting properties, and human exposure pathways investigated in studies from institutions like Harvard University, University of California, Berkeley, and National Institutes of Health. Sites associated with historical operations were subjects of remediation under frameworks including Superfund and national contaminated-site programs. The company implemented risk-reduction programs, product stewardship initiatives, and transitions toward alternatives in response to actions by regulators such as European Chemicals Agency and advocacy from organizations like Greenpeace and Environmental Defense Fund.

Legal and Regulatory Matters

Chemtura engaged in regulatory compliance with evolving chemical management regimes including Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) in the European Union and reporting requirements under the Toxic Substances Control Act in the United States. It faced litigation and settlement negotiations relating to legacy contamination, product liability claims, and patent disputes with competitors and suppliers. Legal actions involved state attorneys general, municipal governments, and private plaintiffs seeking remediation funding or damages, echoing cases involving firms like DuPont, Monsanto, and 3M. Patent and intellectual property portfolios were managed through interactions with the United States Patent and Trademark Office and the European Patent Office.

Corporate Governance and Ownership

Chemtura's board and executive leadership oversaw strategic direction, investor relations, and corporate governance practices to meet standards expected by stock exchanges and institutional investors such as Nasdaq and major asset managers. Leadership transitions included chief executives and board members drawn from chemical and industrial sectors with prior roles at companies like Occidental Petroleum Corporation and ExxonMobil. Shareholder activism, merger negotiations, and takeover discussions culminated in the 2017 acquisition by LANXESS AG, after which many assets were integrated into LANXESS's specialty chemicals divisions and subject to post-merger restructuring influenced by European competition authorities.

Category:Chemical companies of the United States Category:Companies established in 2005 Category:2017 mergers and acquisitions